Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions

Diabetes and Vascular Disease Research

Volumn 10, Issue 1, 2013, Pages 49-56

  Zhang, Jie ^a   Zhang, Xiaoyun ^a   Li, Hong ^a   Cui, Xiaodong ^a   Guan, Xiumei ^a   Tang, Kexin ^a   Jin, Chengwen ^a   Cheng, Min ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

diabetes; Endothelial progenitor cells; hyperglycaemia; vasoactive substances

Indexed keywords

ANGIOGENIC FACTOR; FIBRINOLYTIC AGENT; GLUCOSE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN; VASODILATOR AGENT;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELLULAR SECRETION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERGLYCEMIA; MONONUCLEAR CELL; NONHUMAN; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; EPOPROSTENOL; GLUCOSE; HYPERGLYCEMIA; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; SUPEROXIDE DISMUTASE; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871607670     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164112444639     Document Type: Article

References (40)

1. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001 ; 49: 554-560 (Pubitemid 32146418)
2. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002 ; 105: 3017-3024 (Pubitemid 34693836)
3. Werner N, Priller J, Laufs U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol. 2002 ; 22: 1567-1572
4. Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes. 2004 ; 53: 195-199 (Pubitemid 38044715)
5. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002 ; 106: 2781-2786 (Pubitemid 35396976)
6. Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005 ; 45: 1449-1457 (Pubitemid 40615617)
7. Mattila TK, de Boer A. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus. Drugs. 2010 ; 70: 2229-2245
8. Aragona M, Giannarelli R, Del Prato S. Intensive insulin treatment and postprandial control in Type 1 diabetes. Acta Biomed. 2005 ; 76 3: 26-30 (Pubitemid 351767158)
9. Chen YH, Lin SJ, Lin FY, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes. 2007 ; 56: 1559-1568
10. Urbich C, Aicher A, Heeschen C, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005 ; 39: 733-742 (Pubitemid 41464410)
11. Krenning G, van Luyn MJ, Harmsen MC. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med. 2009 ; 15: 180-189
12. Yang Z, von Ballmoos MW, Faessler D, et al. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis. 2010 ; 211: 103-109
13. Yoon CH, Hur J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation. 2005 ; 112: 1618-1627 (Pubitemid 41324524)
14. Wang F, Xue J, Wang D, et al. Treatment of atherosclerosis by transplantation of bone endothelial progenitor cells over-expressed paraoxonase-1 gene by recombinant adeno-associated virus in rat. Biol Pharm Bull. 2010 ; 33: 1806-1813
15. Medina RJ, Kataoka K, Miyazaki M, et al. Efficient differentiation into skin cells of bone marrow cells recovered in a pellet after density gradient fractionation. Int J Mol Med. 2006 ; 17: 721-727
16. Potenza MA, Gagliardi S, Nacci C, et al. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009 ; 16: 94-112
17. Krankel N, Adams V, Linke A, et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol. 2005 ; 25: 698-703 (Pubitemid 40463856)
18. Murohara T. Cord blood-derived early outgrowth endothelial progenitor cells. Microvasc Resh. 2010 ; 79: 174-177
19. Berkowitz BA, Bissig D, Ye Y, et al. Evidence for diffuse central retinal edema in vivo in diabetic male Sprague Dawley rats. PLoS One. 2012 ; 7: e29619
20. Yue JT, Burdett E, Coy DH, et al. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats. Diabetes. 2012 ; 61: 197-207
21. Desjardins F, Balligand JL. Nitric oxide-dependent endothelial function and cardiovascular disease. Acta Clin Belg. 2006 ; 61: 326-334
22. Du XL, Edelstein D, Dimmeler S, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. The Journal of clinical investigation. 2001 ; 108: 1341-1348 (Pubitemid 33107762)
23. Ozuyaman B, Ebner P, Niesler U, et al. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost. 2005 ; 94: 770-772 (Pubitemid 41489235)
24. Urao N, Okigaki M, Yamada H, et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circul Res. 2006 ; 98: 1405-1413 (Pubitemid 43948065)
25. Dernbach E, Urbich C, Brandes RP, et al. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood. 2004 ; 104: 3591-3597 (Pubitemid 39564432)
26. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res. 2005 ; 96: 818-822 (Pubitemid 40604964)
27. Hamed S, Brenner B, Aharon A, et al. Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus. Cardiovasc Diabetol. 2009 ; 8: 56-67
28. Thum T, Fraccarollo D, Schultheiss M, et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes. 2007 ; 56: 666-674 (Pubitemid 46348461)
29. Turkseven S, Kruger A, Mingone CJ, et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol. 2005 ; 289: H701 - H707
30. He T, Peterson TE, Holmuhamedov EL, et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol. 2004 ; 24: 2021-2027 (Pubitemid 39482424)
31. Tao J, Yang Z, Wang JM, et al. Shear stress increases Cu/Zn SOD activity and mRNA expression in human endothelial progenitor cells. J Hum Hypertens. 2007 ; 21: 353-358 (Pubitemid 46637941)
32. Hanke H, Lenz C, Finking G. The discovery of the pathophysiological aspects of atherosclerosis-a review. Acta Chir Belg. 2001 ; 101: 162-169 (Pubitemid 33636943)
33. Shirota T, He H, Yasui H, et al. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng. 2003 ; 9: 127-136 (Pubitemid 36228184)
34. Yokoyama C, Yabuki T, Shimonishi M, et al. Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction. Circulation. 2002 ; 106: 2397-2403 (Pubitemid 35244744)
35. Szekacs B, Vajo Z, Juhasz I, et al. Glomerular prostanoid production is modified by plasma samples of hypertensive and diabetic patients. Acta Physiol Hung. 1997 ; 85: 17-28 (Pubitemid 128497271)
36. Iwase E, Tawata M, Aida K, et al. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism. 1998 ; 47: 699-705 (Pubitemid 28265175)
37. Demirtunc R, Duman D, Basar M, et al. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications. 2009 ; 23: 89-94
38. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003 ; 9: 669-676 (Pubitemid 36749215)
39. Zhang F, Tang Z, Hou X, et al. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci USA. 2009 ; 106: 6152-6157
40. Abid MR, Schoots IG, Spokes KC, et al. Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J Biol Chem. 2004 ; 279: 44030-44038 (Pubitemid 39390712)